Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension
{{output}}
Objective: The objective of the study is to review the characteristics, efficacy, safety, and clinical relevance of sotatercept in pulmonary arterial hypertension (PAH). Data Sources: A literature search containing search terms related to sotatercept and PAH w... ...
